Login / Signup
Irinotecan and vandetanib create synergies for treatment of pancreatic cancer patients with concomitant TP53 and KRAS mutations.
Aman Chandra Kaushik
Yanjing Wang
Xiangeng Wang
Dong-Qing Wei
Published in:
Briefings Bioinform. (2021)
Keyphrases
</>
cancer patients
breast cancer
clinical data
clinical trials
prostate cancer
treatment plan
treatment planning
breast cancer patients
data sets
cancer classification
radiation therapy
databases
feature selection
microarray
lymph nodes